Vision science at UCSF currently ranks among the top three eye institutions nationally in receipt of grants for sight-saving research, according to a recent survey that examines National Institutes for Health (NIH) funding. U.S. News & World Report again names UCSF Ophthalmology among the top ten in the nation for patient care.
Although more than 70 percent of NIH applications are denied support, 18 UCSF clinical and laboratory scientists were awarded $7.6 million in NIH grant funds in 2009-2010, among the top five recipients in the country. New grants fund basic science and clinical projects.
Research devoted to retinal physiology and disease, glaucoma physiology and disease, and external and immunological disease demonstrates the breadth and depth of UCSF vision science.
Dr. Stephen McLeod, chair of the Department of Ophthalmology, expresses the importance of advancing vision research, “From basic visual sciences through the development of new therapeutic agents, devices, and procedures to the implementation of clinical trials that determine the most effective strategies for implementation locally and globally, these NIH awards allow our outstanding faculty to advance research that brings new solutions to our patients,” says Dr. Stephen McLeod, chair of the Department of Ophthalmology.
Original lines of research are vital for halting blindness and visual disability. Private seed funds nurture and develop these fresh approaches. Government funding becomes possible once investigators can demonstrate results.
Lead and major gifts anchor multi-year investigations by specialized teams, driven to solve the most pressing challenges in ophthalmology.